Peng Dayong

Dr. Peng Dayong

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 December 2022 in Journal of Molecular Structure
Verified
Journal Article
Closed access
ZLZhong Liang
Zhong Liang
ZRZeng Rong
Zeng Rong
HCHuang Cong
Huang Cong
DQDing Qing-Ying
Ding Qing-Ying
SMShi Ming-Zhu
Shi Ming-Zhu
PDPeng Dayong
Peng Dayong

1 January 2020 in Journal of Enzyme Inhibition and Medicinal Chemistry
Verified
Journal Article
Open access
PLPing Lin
Ping Lin
JZJia-Cheng Zeng
Jia-Cheng Zeng
JCJi-Guang Chen
Ji-Guang Chen
XNXu-Liang Nie
Xu-Liang Nie
EYEn Yuan
En Yuan
ZYZhongping Yin
Zhongping Yin
A series of novel N-alkyl-1-deoxynojirimycin derivatives 25 ∼ 44 were synthesised and evaluated for their in vitro α-glucosidase inhibitory activity to develop α-glucosidase inhibitors with high activity. All twenty compounds exhibited α-glucosidase inhibitory activity with IC50 values ranging from 30.0 ± 0.6 µM to 2000 µM as compared to standard acarbose (IC50 = 822.0 ± 1.5 µM). The most active compound 43 was ∼27-fold more active than acarbose. Kinetic study revealed that compounds 43, 40, and 34 were all competitive inhibitors on α-glucosidase with Ki of 10 µM, 52 µM, and 150 µM, respectively. Molecular docking demonstrated that the high active inhibitors interacted with α-glucosidase by four types of interactions, including hydrogen bonds, π–π stacking interactions, hydrophobic interactions, and electrostatic interaction. Among all the interactions, the π–π stacking interaction and hydrogen bond played a significant role in a various range of activities of the compounds.

14 August 2023 in Crystals
Verified
Journal Article
Open access
PDF file
RZRong Zeng
Rong Zeng
CHcong huang
cong huang
JWJie Wang
Jie Wang
YZYuan Zhong
Yuan Zhong
QFQingwen Fang
Qingwen Fang
PDPeng Dayong
Peng Dayong
In this paper, four new compounds with quinazolinone structure were designed and synthesized based on the special biological activity of quinazolinone. The four new compounds containing quinazolinone structures were synthesized using a one-pot method after intramolecular cyclization and dehydration catalyzed by aqueous methylamine solution. Their structures were characterized using 1H NMR, 13C NMR, FT-IR, and HRMS, and the crystal structure of 2a was characterized using X-ray diffraction. In their potential antifungal activity tests, it was found that the four newly synthesized compounds exhibited significant antifungal activity against all seven phytopathogenic fungi at concentrations of 150 and 300 mg/L. Among them, the target compound 2c showed the best inhibitory effect against Fusarium oxysporum f. sp. Niveum fungus, with 62.42% inhibition at a concentration of 300 mg/L. Compound 2c is expected to be a leading compound for the treatment of watermelon Fusarium wilt in the future, which is worth further study.

26 March 2022 in Molecules
Verified
Journal Article
Open access
PDF file
FZFanxin Zeng
Fanxin Zeng
TLTao Lu
Tao Lu
JWJie Wang
Jie Wang
XNXuliang Nie
Xuliang Nie
WXWanming Xiong
Wanming Xiong
PDPeng Dayong
Peng Dayong
Coumarin possesses the aromatic group and showed plentiful activities, such as antioxidant, preventing asthma and antisepsis. In addition, coumarin derivatives usually possess good solubility, low cytotoxicity and excellent cell permeability. In our study, we synthesized the compound bridge methylene tacrine (BMT), which has the classical pharmacophore structure of Tacrine (THA). Based on the principle of active substructure splicing, BMT was used as a lead compound and synthesized coumarin–BMT hybrids by introducing coumarin to BMT. In this work, 21 novel hybrids of BMT and coumarin were synthesized and evaluated for their inhibitory activity on AChE. All obtained compounds present preferable inhibition. Compound 8b was the most active compound, with the value of Ki as 49.2 nM, which was higher than Galantamine (GAL) and lower than THA. The result of molecular docking showed that the highest binding free energy was −40.43 kcal/mol for compound 8b, which was an identical trend with the calculated Ki.

11 September 2019 in Molecules
Verified
Journal Article
Open access
PDF file
FZFanxin Zeng
Fanxin Zeng
ZYZhongping Yin
Zhongping Yin
JCJiguang Chen
Jiguang Chen
XNXuliang Nie
Xuliang Nie
PLPing Lin
Ping Lin
PDPeng Dayong
Peng Dayong
To obtain α-glucosidase inhibitors with high activity, 19 NB-DNJDs (N-benzyl-deoxynojirimycin derivatives) were designed and synthesized. The results indicated that the 19 NB-DNJDs displayed different inhibitory activities towards α-glucosidase in vitro. Compound 18a (1-(4-hydroxy-3-methoxybenzyl)-2-(hydroxymethyl) piperidine-3,4,5-triol) showed the highest activity, with an IC50 value of 0.207 ± 0.11 mM, followed by 18b (1-(3-bromo-4-hydroxy-5-methoxybenzyl)-2-(hydroxymethyl) piperidine-3,4,5-triol, IC50: 0.276 ± 0.13 mM). Both IC50 values of 18a and 18b were significantly lower than that of acarbose (IC50: 0.353 ± 0.09 mM). According to the structure-activity analysis, substitution of the benzyl and bromine groups on the benzene ring decreased the inhibition activity, while methoxy and hydroxyl group substitution increased the activity, especially with the hydroxyl group substitution. Molecular docking results showed that three hydrogen bonds were formed between compound 18a and amino acids in the active site of α-glucosidase. Additionally, an arene–arene interaction was also modelled between the phenyl ring of compound 18a and Arg 315. The three hydrogen bonds and the arene–arene interaction resulted in a low binding energy (−5.8 kcal/mol) and gave 18a a higher inhibition activity. Consequently, compound 18a is a promising candidate as a new α-glucosidase inhibitor for the treatment of type Ⅱ diabetes.

5 May 2015 in Inflammation
Verified
Journal Article
Closed access
PDF file
SLShufeng Li
Shufeng Li
YRYanjun Ren
Yanjun Ren
PDPeng Dayong
Peng Dayong
Zhen YuanZhen Yuan
Zhen Yuan
SSShiying Shan
Shiying Shan
HSHaihan Song
Haihan Song